PRTA FY 2013 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$516M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$676,000-74.6% YoY

Gross Profit

-$25M-3753.8% margin

Operating Income

-$40M-5980.3% margin

Net Income

-$41M-6064.5% margin

EPS (Diluted)

$-2.20

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$33M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$182M

Total Liabilities

$9M

Stockholders' Equity

$173M

Cash & Equivalents

$177M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$676,000	$3M	-74.6%
Gross Profit	-$25M	-$31M	+19.4%
Operating Income	-$40M	-$41M	+2.4%
Net Income	-$41M	-$41M	+1.0%